Laura Valerio

Siena, 53100, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 43 publications

Familial Status Modulates the Stability of Excellent Response in Non-Medullary Thyroid Carcinoma: Implications for Tailored Surveillance.

Familial Status Modulates the Stability of Excellent Response in Non-Medullary Thyroid Carcinoma: Implications for Tailored Surveillance.

Journal: Cancers

Published: March 25, 2026

Gender impact on safety and efficacy in lenvatinib treated patients with radioiodine-refractory differentiated thyroid cancer (GISEL study).

Gender impact on safety and efficacy in lenvatinib treated patients with radioiodine-refractory differentiated thyroid cancer (GISEL study).

Journal: European thyroid journal

Published: December 11, 2024

Multikinase and highly selective kinase inhibitors in the neoadjuvant treatment of patients with thyroid cancer.

Multikinase and highly selective kinase inhibitors in the neoadjuvant treatment of patients with thyroid cancer.

Journal: Exploration of targeted anti-tumor therapy

Published: November 14, 2024

Prophylactic central neck dissection in clinically node-negative papillary thyroid carcinoma: 10-year impact on surgical and oncologic outcomes.

Prophylactic central neck dissection in clinically node-negative papillary thyroid carcinoma: 10-year impact on surgical and oncologic outcomes.

Journal: Surgery

Published: August 13, 2024

Exploring the Susceptibility to Multiple Primary Tumors in Patients with Differentiated Thyroid Cancer.

Exploring the Susceptibility to Multiple Primary Tumors in Patients with Differentiated Thyroid Cancer.

Journal: Diagnostics (Basel, Switzerland)

Published: May 11, 2024

A post-irradiation-induced replication stress promotes RET proto-oncogene breakage.

A post-irradiation-induced replication stress promotes RET proto-oncogene breakage.

Journal: European thyroid journal

Published: January 29, 2024

Hand-foot syndrome in sorafenib and lenvatinib treatment for advanced thyroid cancer.

Hand-foot syndrome in sorafenib and lenvatinib treatment for advanced thyroid cancer.

Journal: European thyroid journal

Published: January 09, 2024

Dynamic Risk Stratification Integrated with ATA Risk System for Predicting Long-Term Outcome in Papillary Thyroid Cancer.

Dynamic Risk Stratification Integrated with ATA Risk System for Predicting Long-Term Outcome in Papillary Thyroid Cancer.

Journal: Cancers

Published: July 20, 2023

Enlargement of a metastatic lymph node from differentiated thyroid cancer after COVID-19 vaccination.

Enlargement of a metastatic lymph node from differentiated thyroid cancer after COVID-19 vaccination.

Journal: Endocrine

Published: March 02, 2023

Prognostic Factors Improving ATA Risk System and Dynamic Risk Stratification in Low- and Intermediate-Risk DTC Patients.

Prognostic Factors Improving ATA Risk System and Dynamic Risk Stratification in Low- and Intermediate-Risk DTC Patients.

Journal: The Journal of clinical endocrinology and metabolism

Published: February 21, 2023

Pilot Study on the Impact of Polymorphisms Linked to Multi-Kinase Inhibitor Metabolism on Lenvatinib Side Effects in Patients with Advanced Thyroid Cancer.

Pilot Study on the Impact of Polymorphisms Linked to Multi-Kinase Inhibitor Metabolism on Lenvatinib Side Effects in Patients with Advanced Thyroid Cancer.

Journal: International journal of molecular sciences

Published: February 03, 2023

Radio-iodine refractory thyroid cancer patients: a tailored follow-up based on clinicopathological features.

Radio-iodine refractory thyroid cancer patients: a tailored follow-up based on clinicopathological features.

Journal: Journal of endocrinological investigation

Published: January 11, 2023

Showing 1-12 of 43

Last Updated: 09/26/2026